Session » Healthcare Disparities in Rheumatology Poster

Date: Sunday, November 5, 2017

Time: 9:00AM-11:00AM

Meeting: 2017 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 225

Barriers to the Use of Methotrexate in Ethiopia: Survey of Pharmacy Providers

9:00AM-11:00AM: Abstract Number: 226

Biopsy Proven Giant Cell Arteritis in African Descent Populations: Incidence and Characteristics in Martinique, French West Indies

9:00AM-11:00AM: Abstract Number: 222

Characterization of Unexpected Autoantibody Specificities in American Indian SLE Patients

9:00AM-11:00AM: Abstract Number: 228

Characterizing Indigenous Community Engagement Patterns in Published Arthritis Studies: A Systematic Review of the Literature

9:00AM-11:00AM: Abstract Number: 227

Chinese-American Rheumatology Patients Who Use Traditional Chinese-Medicine Have Worse Patient Reported Outcomes

9:00AM-11:00AM: Abstract Number: 223

Decreased Medication Adherence Is a Major Cause for Increased Risk of Hospitalizations Among High Risk Lupus Patients

9:00AM-11:00AM: Abstract Number: 219

Disparities in Patients’ Expectations of Foot and Ankle Surgery

9:00AM-11:00AM: Abstract Number: 229

Divergent Measures of Lupus Disease Damage and Severity Among Asians in an Ethnically Diverse Cohort

9:00AM-11:00AM: Abstract Number: 221

Do Immigrant Communities Play a Role in Total Knee Arthroplasty (TKA) Outcomes?

9:00AM-11:00AM: Abstract Number: 220

English Language Proficiency and Total Joint Replacement Outcomes: Is There a Relationship?

9:00AM-11:00AM: Abstract Number: 224

Patterns of Methotrexate Use in African Countries with Low Versus Medium/High Human Development Index: Preliminary Results of Semi-Structured Interviews

9:00AM-11:00AM: Abstract Number: 218

Social Factors and Racial Disparities in Total Hip Arthroplasty Outcomes

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].